AAAAAA

   
Results: 1-24 |
Results: 24
SIZE AND DURATION OF ZIDOVUDINE BENEFIT IN 1003 HIV-INFECTED PATIENTS- US ARMY, NAVY, AND AIR-FORCE NATURAL-HISTORY DATA
Authors: GARDNER LI HARRISON SH HENDRIX CW BLATT SP WAGNER KF CHUNG RCY HARRIS RW COHN DL BURKE DS MAYERS DL
Citation: Li. Gardner et al., SIZE AND DURATION OF ZIDOVUDINE BENEFIT IN 1003 HIV-INFECTED PATIENTS- US ARMY, NAVY, AND AIR-FORCE NATURAL-HISTORY DATA, Journal of acquired immune deficiency syndromes and human retrovirology, 17(4), 1998, pp. 345-353
PHARMACOKINETICS AND SAFETY OF ORAL LEVOFLOXACIN IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED INDIVIDUALS RECEIVING CONCOMITANT ZIDOVUDINE
Authors: CHIEN SC CHOW AT ROGGE MC WILLIAMS RR HENDRIX CW
Citation: Sc. Chien et al., PHARMACOKINETICS AND SAFETY OF ORAL LEVOFLOXACIN IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED INDIVIDUALS RECEIVING CONCOMITANT ZIDOVUDINE, Antimicrobial agents and chemotherapy, 41(8), 1997, pp. 1765-1769
ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) ACTIVITY, SAFETY, AND PHARMACOKINETICS OF ADEFOVIR DIPIVOXIL PIVALOYLOXYMETHYL)-PHOSPHONYLMETHOXYETHYL]ADENINE) IN HIV-INFECTED PATIENTS
Authors: BARDITCHCROVO P TOOLE J HENDRIX CW CUNDY KC EBELING D JAFFE HS LIETMAN PS
Citation: P. Barditchcrovo et al., ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) ACTIVITY, SAFETY, AND PHARMACOKINETICS OF ADEFOVIR DIPIVOXIL PIVALOYLOXYMETHYL)-PHOSPHONYLMETHOXYETHYL]ADENINE) IN HIV-INFECTED PATIENTS, The Journal of infectious diseases, 176(2), 1997, pp. 406-413
ANTIGEN-STIMULATED APOPTOTIC T-CELL DEATH IN HIV-INFECTION IS SELECTIVE FOR CD4-CELLS, MODULATED BY CYTOKINES AND EFFECTED BY LYMPHOTOXIN( T)
Authors: CLERICI M SARIN A BERZOFSKY JA LANDAY AL KESSLER HA HASHEMI F HENDRIX CW BLATT SP RUSNAK J DOLAN MJ COFFMAN RL HENKART PA SHEARER GM
Citation: M. Clerici et al., ANTIGEN-STIMULATED APOPTOTIC T-CELL DEATH IN HIV-INFECTION IS SELECTIVE FOR CD4-CELLS, MODULATED BY CYTOKINES AND EFFECTED BY LYMPHOTOXIN( T), AIDS, 10(6), 1996, pp. 603-611
MODIFICATION OF THE IMMUNE-RESPONSE IN HIV-INFECTION BY TYPE-1 TYPE-2CYTOKINE REGULATION
Authors: CLERICI M SARIN A LUCEY DR PINTO LA WYNN TA BLATT SP HENDRIX CW DOLAN MJ WOLF SF BERZOFSKY JA HENKART PA SHEARER GM
Citation: M. Clerici et al., MODIFICATION OF THE IMMUNE-RESPONSE IN HIV-INFECTION BY TYPE-1 TYPE-2CYTOKINE REGULATION, Journal of cellular biochemistry, 1995, pp. 60-60
MODULATION OF ALPHA-INTERFERONS ANTIVIRAL AND CLINICAL EFFECTS BY ASPIRIN, ACETAMINOPHEN, AND PREDNISONE IN HEALTHY-VOLUNTEERS
Authors: HENDRIX CW PETTY BG WOODS A KUWAHARA SK WITTER FR SOO W GRIFFIN DE LIETMAN PS
Citation: Cw. Hendrix et al., MODULATION OF ALPHA-INTERFERONS ANTIVIRAL AND CLINICAL EFFECTS BY ASPIRIN, ACETAMINOPHEN, AND PREDNISONE IN HEALTHY-VOLUNTEERS, Antiviral research, 28(2), 1995, pp. 121-131
IN-VITRO T-CELL FUNCTION, DELAYED-TYPE HYPERSENSITIVITY SKIN TESTING,AND CD4(-CELL SUBSET PHENOTYPING INDEPENDENTLY PREDICT SURVIVAL-TIME IN PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS() T)
Authors: DOLAN MJ CLERICI M BLATT SP HENDRIX CW MELCHER GP BOSWELL RN FREEMAN TM WARD W HENSLEY R SHEARER GM
Citation: Mj. Dolan et al., IN-VITRO T-CELL FUNCTION, DELAYED-TYPE HYPERSENSITIVITY SKIN TESTING,AND CD4(-CELL SUBSET PHENOTYPING INDEPENDENTLY PREDICT SURVIVAL-TIME IN PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS() T), The Journal of infectious diseases, 172(1), 1995, pp. 79-87
CONSIDERATION OF THE PREVALENCE OF CYTOMEGALOVIRUS RETINITIS SIGNIFICANTLY ALTERS THE ASSESSMENT OF A SERUM CYTOMEGALOVIRUS DNA TEST
Authors: HENDRIX CW
Citation: Cw. Hendrix, CONSIDERATION OF THE PREVALENCE OF CYTOMEGALOVIRUS RETINITIS SIGNIFICANTLY ALTERS THE ASSESSMENT OF A SERUM CYTOMEGALOVIRUS DNA TEST, The Journal of infectious diseases, 171(6), 1995, pp. 1688-1689
MULTIVARIATE MODELS FOR PREDICTING PROGRESSION TO AIDS AND SURVIVAL IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PERSONS
Authors: BLATT SP MCCARTHY WF BUCKOKRASNICKA B MELCHER GP BOSWELL RN DOLAN MJ FREEMAN TM RUSNAK JM HENSLEY RE WARD WW BARNES D HENDRIX CW
Citation: Sp. Blatt et al., MULTIVARIATE MODELS FOR PREDICTING PROGRESSION TO AIDS AND SURVIVAL IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PERSONS, The Journal of infectious diseases, 171(4), 1995, pp. 837-844
LEGIONNAIRES-DISEASE IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS - 8 CASES AND REVIEW
Authors: BLATT SP DOLAN MJ HENDRIX CW MELCHER GP
Citation: Sp. Blatt et al., LEGIONNAIRES-DISEASE IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS - 8 CASES AND REVIEW, Clinical infectious diseases, 18(2), 1994, pp. 227-232
VALIDATION OF POST-ACIDIFICATION P24-ANTIGEN AS A PROGNOSTIC MARKER FOR HIV DISEASE PROGRESSION
Authors: ASCHER DP BLATT SP HENDRIX CW ROBERTS C FOWLER A
Citation: Dp. Ascher et al., VALIDATION OF POST-ACIDIFICATION P24-ANTIGEN AS A PROGNOSTIC MARKER FOR HIV DISEASE PROGRESSION, AIDS patient care, 8(5), 1994, pp. 251-253
VALIDATION OF POST-ACIDIFICATION P24-ANTIGEN AS A PROGNOSTIC MARKER FOR HIV DISEASE PROGRESSION
Authors: ASCHER DP BLATT SP HENDRIX CW ROBERTS C FOWLER A
Citation: Dp. Ascher et al., VALIDATION OF POST-ACIDIFICATION P24-ANTIGEN AS A PROGNOSTIC MARKER FOR HIV DISEASE PROGRESSION, AIDS patient care, 8(5), 1994, pp. 251-253
EFFECT OF DIPYRIDAMOLE ON ZIDOVUDINE PHARMACOKINETICS AND SHORT-TERM TOLERANCE IN ASYMPTOMATIC HUMAN IMMUNODEFICIENCY VIRUS-INFECTED SUBJECTS
Authors: HENDRIX CW FLEXNER C SZEBENI J KUWAHARA S PENNYPACKER S WEINSTEIN JN LIETMAN PS
Citation: Cw. Hendrix et al., EFFECT OF DIPYRIDAMOLE ON ZIDOVUDINE PHARMACOKINETICS AND SHORT-TERM TOLERANCE IN ASYMPTOMATIC HUMAN IMMUNODEFICIENCY VIRUS-INFECTED SUBJECTS, Antimicrobial agents and chemotherapy, 38(5), 1994, pp. 1036-1040
TYPE-1 TYPE-2 CYTOKINE MODULATION OF T-CELL PROGRAMMED CELL-DEATH AS A MODEL FOR HUMAN-IMMUNODEFICIENCY-VIRUS PATHOGENESIS
Authors: CLERICI M SARIN A COFFMAN RL WYNN TA BLATT SP HENDRIX CW WOLF SF SHEARER GM HENKART PA
Citation: M. Clerici et al., TYPE-1 TYPE-2 CYTOKINE MODULATION OF T-CELL PROGRAMMED CELL-DEATH AS A MODEL FOR HUMAN-IMMUNODEFICIENCY-VIRUS PATHOGENESIS, Proceedings of the National Academy of Sciences of the United Statesof America, 91(25), 1994, pp. 11811-11815
INHIBITION OF ACTIVATION-INDUCED PROGRAMMED CELL-DEATH AND RESTORATION OF DEFECTIVE IMMUNE-RESPONSES OF HIV+ DONORS BY CYSTEINE PROTEASE INHIBITORS
Authors: SARIN A CLERICI M BLATT SP HENDRIX CW SHEARER GM HENKART PA
Citation: A. Sarin et al., INHIBITION OF ACTIVATION-INDUCED PROGRAMMED CELL-DEATH AND RESTORATION OF DEFECTIVE IMMUNE-RESPONSES OF HIV+ DONORS BY CYSTEINE PROTEASE INHIBITORS, The Journal of immunology, 153(2), 1994, pp. 862-872
ROLE OF INTERLEUKIN-10 IN T-HELPER CELL DYSFUNCTION IN ASYMPTOMATIC INDIVIDUALS INFECTED WITH THE HUMAN-IMMUNODEFICIENCY-VIRUS
Authors: CLERICI M WYNN TA BERZOFSKY JA BLATT SP HENDRIX CW SHER A COFFMAN RL SHEARER GM
Citation: M. Clerici et al., ROLE OF INTERLEUKIN-10 IN T-HELPER CELL DYSFUNCTION IN ASYMPTOMATIC INDIVIDUALS INFECTED WITH THE HUMAN-IMMUNODEFICIENCY-VIRUS, The Journal of clinical investigation, 93(2), 1994, pp. 768-775
REAL-TIME MOLECULAR EPIDEMIOLOGIC ANALYSIS OF AN OUTBREAK OF STREPTOCOCCUS-PYOGENES INVASIVE DISEASE IN US AIR-FORCE TRAINEES
Authors: MUSSER JM KAPUR V PETERS JE HENDRIX CW DREHNER D GACKSTETTER GD SKALKA DR FORT PL MAFFEI JT LI LL MELCHER GP
Citation: Jm. Musser et al., REAL-TIME MOLECULAR EPIDEMIOLOGIC ANALYSIS OF AN OUTBREAK OF STREPTOCOCCUS-PYOGENES INVASIVE DISEASE IN US AIR-FORCE TRAINEES, Archives of pathology and laboratory medicine, 118(2), 1994, pp. 128-133
DELAYED-TYPE HYPERSENSITIVITY AND AIDS - RESPONSE
Authors: BLATT SP HENDRIX CW
Citation: Sp. Blatt et Cw. Hendrix, DELAYED-TYPE HYPERSENSITIVITY AND AIDS - RESPONSE, Annals of internal medicine, 120(4), 1994, pp. 344-344
MEASUREMENT OF CEREBROSPINAL-FLUID ANTIBODY TO THE HIV-1 PRINCIPAL NEUTRALIZING DETERMINANT (V3 LOOP)
Authors: LUCEY DR VANCOTT TC LOOMIS LD BETHKE FR HENDRIX CW MELCHER GP REDFIELD RR BIRX DL
Citation: Dr. Lucey et al., MEASUREMENT OF CEREBROSPINAL-FLUID ANTIBODY TO THE HIV-1 PRINCIPAL NEUTRALIZING DETERMINANT (V3 LOOP), Journal of acquired immune deficiency syndromes, 6(9), 1993, pp. 994-1001
RESTORATION OF HIV-SPECIFIC CELL-MEDIATED IMMUNE-RESPONSES BY INTERLEUKIN-12 IN-VITRO
Authors: CLERICI M LUCEY DR BERZOFSKY JA PINTO LA WYNN TA BLATT SP DOLAN MJ HENDRIX CW WOLF SF SHEARER GM
Citation: M. Clerici et al., RESTORATION OF HIV-SPECIFIC CELL-MEDIATED IMMUNE-RESPONSES BY INTERLEUKIN-12 IN-VITRO, Science, 262(5140), 1993, pp. 1721-1724
LONGITUDINAL ANALYSIS OF THE HUMORAL IMMUNE-RESPONSE TO HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) GP160 EPITOPES IN RAPIDLY PROGRESSING AND NONPROGRESSING HIV-1-INFECTED SUBJECTS
Authors: WONG MT WARREN RQ ANDERSON SA DOLAN MJ HENDRIX CW BLATT SP MELCHER GP BOSWELL RN KENNEDY RC
Citation: Mt. Wong et al., LONGITUDINAL ANALYSIS OF THE HUMORAL IMMUNE-RESPONSE TO HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) GP160 EPITOPES IN RAPIDLY PROGRESSING AND NONPROGRESSING HIV-1-INFECTED SUBJECTS, The Journal of infectious diseases, 168(6), 1993, pp. 1523-1527
EFFECT OF A RECOMBINANT CD4-IGG ON IN-VITRO T-HELPER CELL-FUNCTION - DATA FROM A PHASE-I II STUDY OF PATIENTS WITH AIDS/
Authors: CLERICI M YARCHOAN R BLATT S HENDRIX CW AMMANN AJ BRODER S SHEARER GM
Citation: M. Clerici et al., EFFECT OF A RECOMBINANT CD4-IGG ON IN-VITRO T-HELPER CELL-FUNCTION - DATA FROM A PHASE-I II STUDY OF PATIENTS WITH AIDS/, The Journal of infectious diseases, 168(4), 1993, pp. 1012-1016
RACIAL-DIFFERENCES IN SERUM BETA-2-MICROGLOBULIN IN PERSONS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
Authors: LUCEY DR MCCARTHY WF BLATT SP MELCHER GP HENDRIX CW
Citation: Dr. Lucey et al., RACIAL-DIFFERENCES IN SERUM BETA-2-MICROGLOBULIN IN PERSONS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION, The Journal of infectious diseases, 167(5), 1993, pp. 1259-1260
DELAYED-TYPE HYPERSENSITIVITY SKIN TESTING PREDICTS PROGRESSION TO AIDS IN HIV-INFECTED PATIENTS
Authors: BLATT SP HENDRIX CW BUTZIN CA FREEMAN TM WARD WW HENSLEY RE MELCHER GP DONOVAN DJ BOSWELL RN
Citation: Sp. Blatt et al., DELAYED-TYPE HYPERSENSITIVITY SKIN TESTING PREDICTS PROGRESSION TO AIDS IN HIV-INFECTED PATIENTS, Annals of internal medicine, 119(3), 1993, pp. 177-184
Risultati: 1-24 |